Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival.
Taniguchi
S
S
Department of Surgery III, Nara Medical College, Japan.
Kitamura
S
S
Kawachi
K
K
Fukutomi
M
M
Yoshida
Y
Y
D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006085:Graft Survival; D006339:Heart Rate; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D010956:Plasmapheresis; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011726:Pyridinium Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology*
D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; C053321:CV 6209